What type of study is this?

This is a Literature Review study.

September 10, 2025European Journal of Anaesthesiology

Development of the neuromuscular junction and neuromuscular blocking agents in neonates, infants and children

View Full Paper

Ask AI

Bookmark

Authors

VSVera SaldienUniversity of Antwerp FVFrancis VeyckemansAntwerp University Hospital THTom G. HansenUniversity of Oslo

Discussion

Member takes

Implication

Narrative review explores pharmacological properties and safety of neuromuscular blocking agents in pediatric populations, highlighting critical differences due to age.

Key Points

Neuromuscular blocking agents ensure effective intubation and mechanical ventilation in neonates and infants, minimizing risks during procedures.
Pharmacokinetic and pharmacodynamic variations in neonates mean dosage adjustments are critical for safety in pediatric anaesthesia.
Monitoring techniques are vital to prevent residual neuromuscular blockade, with advancements improving safety in neonatal populations.
Current research trends emphasize the need for age-specific guidelines and pharmacological innovations to optimize NMBA use.

Cite This Study

Saldien et al. (2025) studied this question.

synapsesocial.com/papers/68c18bf99b7b07f3a06141ad https://doi.org/10.1097/eja.0000000000002270

View Full Paper

Ask AI

Bookmark

Implication

Narrative review explores pharmacological properties and safety of neuromuscular blocking agents in pediatric populations, highlighting critical differences due to age.

Development of the neuromuscular junction and neuromuscular blocking agents in neonates, infants and children

Discussion

Member takes

Implication

Key Points

Cite This Study

Development of the neuromuscular junction and neuromuscular blocking agents in neonates, infants and children

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider